HSGX - Histogenics Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.59M
Enterprise Value 319.58M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.82

Trading Information

Stock Price History

Beta (3Y Monthly) 4.14
52-Week Change 3-91.80%
S&P500 52-Week Change 37.27%
52 Week High 33.0000
52 Week Low 30.0800
50-Day Moving Average 30.2043
200-Day Moving Average 30.1665

Share Statistics

Avg Vol (3 month) 37.78M
Avg Vol (10 day) 35.71M
Shares Outstanding 5N/A
Float 88.79M
% Held by Insiders 16.44%
% Held by Institutions 110.94%
Shares Short (Jun 28, 2019) 44.51M
Short Ratio (Jun 28, 2019) 40.41
Short % of Float (Jun 28, 2019) 45.08%
Short % of Shares Outstanding (Jun 28, 2019) 44.77%
Shares Short (prior month May 31, 2019) 44.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-83.85%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.97M
Net Income Avi to Common (ttm)-3.55M
Diluted EPS (ttm)-0.4870
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.38M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)8.04M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.51
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-27.55M
Levered Free Cash Flow (ttm)-21.39M